²úÆ·¹©Ó¦±½ßò²Ýͪ

  • ·¢²¼ÈÕÆÚ£º2024-12-31
  • ÓÐЧÆÚÏÞ£º30Ìì
³£ÖÝÊÐâù¶«»¯¹¤ÓÐÏÞ¹«Ë¾ VIP
C16H17N3O5S
363.3883

ÏêϸÐÅÏ¢
  • [3-(4,5-dihydro-1,2-oxazol-3-yl)-2-methyl-4-(methylsulfonyl)phenyl](5-hydroxy-1-methyl-1H-pyrazol-4-yl)methanone
  • ;210631-68-8;T5NO EUTJ ER B1 FSW1 CV- DTNNJ A1 EQ;topramezone;topram¨¦zone;
  • InChI=1/C16H17N3O5S/c1-9-10(15(20)11-8-17-19(2)16(11)21)4-5-13(25(3,22)23)14(9)12-6-7-24-18-12/h4-5,8,21H,6-7H2,1-3H3
  • 1.492g/cm3
  • 590.491¡ãC at 760 mmHg
  • 310.918¡ãC
  • CAS NO£º210631-68-8

ÃâÔðÉùÃ÷£ºÒÔÉÏËùչʾµÄÐÅÏ¢ÓÉÆóÒµ×ÔÐÐÌṩ£¬ÄÚÈݵÄÕæʵÐÔ¡¢×¼È·ÐԺͺϷ¨ÐÔÓÉ·¢²¼ÆóÒµ¸ºÔ𣬻¯¹¤Íø¶Ô´Ë²»³Ðµ£Èκα£Ö¤ÔðÈΡ£ÎÒÃÇÔ­ÔòÉϽ¨ÒéÄúÑ¡Ôñ»¯¹¤Íø¸ß¼¶»áÔ±»òVIP»áÔ±¡£